Document Classification

Section Type: METHODS

Text: Premenopausal women with lymph node positive breast carcinoma were stratified according to age (younger than 35 or 35 years or older) and the number of positive axillary lymph nodes (1-3, 4-9, or > / = 10) and then randomly assigned to receive either doxorubicin 40 mg/m (2) and cyclophosphamide 600 mg/m (2) intravenously (i. v.) every 3 weeks or cyclophosphamide 100 mg/m (2) orally on Days 1 through 14, methotrexate 40 mg/m (2) and 5-fluorouracil 500 mg/m (2) i. v. on Days 1 and 8 every 4 weeks.